Grant: Innovative Solutions Canada
PharmaPlanter Technologies Inc
$150,000.00
Development of plant-based Nrf2 activator therapeutics to alleviate the severe complications of respiratory diseases
EF 2022-23 · 2023-01-03
Résumé
National Research Council of Canada (NRC) is seeking potential therapeutics (ideally sub-micromolar potent) to treat respiratory disease by targeting viral infection, replication and/or address associated co-morbidities.
Ministère
Programme
Innovative Solutions Canada
Bénéficiaire
Emplacement
Burnaby|Burnaby, British Columbia, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
821214632
Type
Grant
Source
Proactive Disclosure - Grants and Contributions
Tel que publié
Agreement End Date
2023-07-03
Agreement Number
999609
Agreement Start Date
2023-01-03
Agreement Title
Development of plant-based Nrf2 activator therapeutics to alleviate the severe complications of respiratory diseases
Agreement Title (French)
Développement de thérapeutiques à base de plantes activatrices de Nrf2 pour atténuer les complications graves des maladies respiratoires
Agreement Type
Grant
Agreement Value
$150,000.00
Amendment Number
0
Coverage
• Support the scale up and growth of Canada's innovators and entrepreneurs by having the federal government act as a first customer. • Stimuler l'expansion et la croissance des innovateurs et entrepreneurs canadiens en faisant du gouvernement fédéral le premier client des innovations canadiennes.
Description
National Research Council of Canada (NRC) is seeking potential therapeutics (ideally sub-micromolar potent) to treat respiratory disease by targeting viral infection, replication and/or address associated co-morbidities.
Description (French)
Le Conseil national de recherches du Canada (CNRC) est à la recherche de produits thérapeutiques potentiels (idéalement sous-micromolaires) pour traiter des maladies respiratoires en ciblant l'infection virale, la réplication ou les comorbidités.
Expected Results
Grow Canadian companies through direct funding to support early stage, pre-commercial research and development, late stage prototypes, and to accelerate commercialization.
Expected Results (French)
Faire croître les sociétés canadiennes au moyen de financement direct versé pour soutenir la recherche-développement (R-D) précommerciale à un stade précoce et les prototypes à un stade avancé et en accélérer la commercialisation.
Federal Riding
Burnaby South
Federal Riding (French)
Burnaby-Sud
Federal Riding Number
59003
NAICS Code
32541
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Innovative Solutions Canada
Program Name (French)
Programme Solutions innovatrices Canada
Program Purpose
Fuel the development and adoption of technological innovation in Canada
Program Purpose (French)
Stimuler le développement et l'adoption de l'innovation technologique au Canada
Recipient Business Number
821214632
Recipient City
Burnaby|Burnaby
Recipient Country
CA
Recipient Legal Name
PharmaPlanter Technologies Inc
Recipient Postal Code
V5M 3Z3
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2022-2023-Q3-999609
Research Organization
National Research Council Canada/Conseil national de recherches Canada
